Preclinical and clinical trials of oncolytic vaccinia virus in cancer immunotherapy: a comprehensive review
Oncolytic virotherapy has emerged as a promising treatment for human cancers owing to an ability to elicit curative effects via systemic administration.Tumor cells often create an unfavorable immunosuppressive microenvironment peavey kb1 that degrade viral structures and impede viral replication; however, recent studies have established that viruse